| 2025 | 2024 | 2023 | 2022 | 2021 | 2019 | 2018 | 2017 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 1,8 M € | — | ||||||||||||||||||
| Gross margin | 253,5 k € | +4.0% | 243,8 k € | -2.0% | 248,8 k € | +3.8% | 239,7 k € | +8.6% | 220,8 k € | -7.6% | 238,9 k € | -0.1% | 239,1 k € | +5.0% | 227,7 k € | +26.8% | 179,6 k € | +35.5% | 132,5 k € | -13.3% | 152,7 k € | -13.0% | 175,5 k € | +6.4% | 164,9 k € | +13.4% | 145,4 k € | -1.0% | 146,9 k € | -13.8% | 170,4 k € | +1.7% | 167,6 k € | +23.7% | 135,5 k € | |
| EBITDA | 163,1 k € | +11.5% | 146,2 k € | -0.4% | 146,8 k € | +19.8% | 122,6 k € | +4.5% | 117,4 k € | +20.4% | 97,4 k € | -19.1% | 120,5 k € | +20.5% | 100,0 k € | +19.5% | 83,6 k € | +13.5% | 73,7 k € | -28.3% | 102,7 k € | -19.1% | 126,9 k € | +0.7% | 126,1 k € | +19.7% | 105,4 k € | +4.7% | 100,6 k € | -19.6% | 125,1 k € | +1.3% | 123,6 k € | +18.2% | 104,6 k € | |
| Operating profit | 93,8 k € | +22.3% | 76,7 k € | -15.9% | 91,2 k € | +22.1% | 74,8 k € | +6.4% | 70,2 k € | +25.9% | 55,8 k € | -27.9% | 77,4 k € | +85.3% | 41,7 k € | +38.4% | 30,2 k € | +46.3% | 20,6 k € | -55.1% | 45,9 k € | -25.2% | 61,3 k € | -9.1% | 67,5 k € | +32.4% | 51,0 k € | -9.7% | 56,4 k € | -37.7% | 90,6 k € | +3.1% | 87,8 k € | +50.7% | 58,3 k € | |
| Profit/loss | 62,4 k € | +34.8% | 46,3 k € | -15.2% | 54,6 k € | +20.6% | 45,2 k € | +12.2% | 40,3 k € | +36.5% | 29,5 k € | -39.9% | 49,1 k € | +233.6% | 14,7 k € | +29.8% | 11,3 k € | +763.6% | 1,3 k € | -92.0% | 16,3 k € | -55.5% | 36,7 k € | -22.0% | 47,1 k € | +45.3% | 32,4 k € | +36.2% | 23,8 k € | -52.1% | 49,6 k € | +1.3% | 49,0 k € | +58.6% | 30,9 k € | |
| Equity | 346,0 k € | +11.1% | 311,5 k € | -4.9% | 327,5 k € | +20.0% | 272,9 k € | +7.5% | 253,9 k € | +52.4% | 166,7 k € | +20.1% | 138,8 k € | +52.1% | 91,2 k € | -25.3% | 122,1 k € | +10.2% | 110,7 k € | +1.2% | 109,4 k € | +6.1% | 103,1 k € | +7.0% | 96,4 k € | +1.1% | 95,3 k € | +0.4% | 94,9 k € | +10.2% | 86,2 k € | -0.5% | 86,6 k € | -0.0% | 86,6 k € | |
| Total assets | 739,2 k € | -8.1% | 804,3 k € | -12.7% | 921,2 k € | +15.0% | 800,8 k € | -2.2% | 819,1 k € | +6.1% | 771,9 k € | -4.0% | 803,8 k € | -13.5% | 929,3 k € | +29.5% | 717,5 k € | -18.0% | 875,4 k € | -17.0% | 1,1 M € | +6.2% | 993,6 k € | -24.5% | 1,3 M € | -4.3% | 1,4 M € | +55.0% | 887,1 k € | +57.2% | 564,3 k € | -13.3% | 651,1 k € | -0.4% | 653,8 k € | |
| Cash | 23,2 k € | +66.7% | 13,9 k € | -80.1% | 70,1 k € | +35.4% | 51,7 k € | +80.2% | 28,7 k € | +21.0% | 23,7 k € | +11.7% | 21,2 k € | -80.1% | 106,5 k € | +88.5% | 56,5 k € | +895.1% | 5,7 k € | +21.8% | 4,7 k € | -95.5% | 103,6 k € | -27.8% | 143,5 k € | +125.9% | 63,5 k € | +56.8% | 40,5 k € | +25.9% | 32,2 k € | -9.7% | 35,6 k € | -72.8% | 131,1 k € | |
| Debts | 388,0 k € | -20.6% | 488,8 k € | -17.4% | 591,6 k € | +12.9% | 523,9 k € | -6.7% | 561,7 k € | -6.7% | 602,1 k € | -9.0% | 662,0 k € | -20.8% | 835,6 k € | +40.7% | 593,9 k € | -22.1% | 762,5 k € | -19.2% | 943,7 k € | +6.2% | 888,7 k € | -27.0% | 1,2 M € | -4.8% | 1,3 M € | +61.7% | 790,1 k € | +65.5% | 477,6 k € | -15.2% | 563,3 k € | -0.6% | 567,0 k € | |
| Staff | 1,2 | 1,3 | 1,5 | 2,4 | 2 | 2 | 2,2 | 2,1 | 1,7 | 1,8 | 0,9 | 0,9 | 0,8 | 0,9 | 0,7 | 0,7 | 0,7 | 0,4 | ||||||||||||||||||
Private limited company · Begijnendijk · incorporated on 27/02/1986 · 1,2 ETP
Private limited company profitable and well capitalised. Cash position rising (+66.7%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
'T BEGIJNTJE is a Private limited company incorporated in 1986. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Begijnendijk. It employs on average 1,2 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette